FDA Safety Communication: FDA Provides Interim Results of Duodenoscope Reprocessing Studies Conducted in Real-World Settings

Stephen B. Hanauer, MD, FACG Chair, ACG FDA Related Matters Committee On December 10, the U.S. Food & Drug Administration (FDA) released interim results from post-market surveillance studies on contamination rates with duodenoscopes after ...